Santiago Olszevicki

SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients

Juan Bizzotto, Pablo Sanchis, Mercedes Abbate et al. · iScience · 2020 · 123 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina

Soledad González, Santiago Olszevicki, Martín R. Salazar et al. · EClinicalMedicine · 2021 · 83 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +13

Real-world effectiveness of RSVpreF vaccination during pregnancy against RSV-associated lower respiratory tract disease leading to hospitalisation in infants during the 2024 RSV season in Argentina (BERNI study): a multicentre, retrospective, test-negative, case–control study

Gonzalo Pérez Marc, Carla Vizzotti, Deshayne B. Fell et al. · The Lancet Infectious Diseases · 2025 · 63 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study

Juan Manuel Castelli, Analía Rearte, Santiago Olszevicki et al. · BMJ · 2022 · 39 citations · Full text

Veterinary Medicine, Child Health, Infectious Diseases +17

Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study

Soledad González, Santiago Olszevicki, Alejandra Gaiano et al. · The Lancet Regional Health - Americas · 2022 · 35 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17